Cite
HARVARD Citation
Li, J. et al. (2016). Synthetic tetracycline-controllable shRNA targeting long non-coding RNA HOXD-AS1 inhibits the progression of bladder cancer. Journal of experimental & clinical cancer research. 35 (1), pp. 1-10. [Online].